Skip to main content
Recall Canary
Trokendi XR (topiramate) Extended-Release Capsules
← Back to all recalls
DRUG RECALLLOW

Trokendi XR (topiramate) Extended-Release Capsules

Trokendi XR (topiramate) 50 mg capsules recalled over failed dissolution specs.

What to do

Consumers with the recalled product should stop using it and contact their pharmacist or physician for guidance. Return the product to the place of purchase for a refund or replacement.

Recalled
Listed
Updated
Agency
FDA
Firm
Supernus Pharmaceuticals, Inc.
Recall ID
99767
Status
ONGOING

Recall at a glance

Quantity recalled
11304 bottles

Why it was recalled

Supernus Pharmaceuticals is recalling Trokendi XR (topiramate) extended-release capsules, 50 mg, 30-count bottles, because they failed dissolution specifications.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Trokendi XR, (topiramate) extended-release capsules

Lot code
2145283, 31-Mar-2030
Strength
50 mg
NDC / UPC
NDC 17772-102-30

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Dissolution Failure recalls

Other recent recalls from Supernus Pharmaceuticals, Inc.

All recalls from Supernus Pharmaceuticals, Inc.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-09-04 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification